Tadakazu Kondo
Kyoto University
245 Papers
746 Citations
Tadakazu Kondo is an academic researcher from Kyoto University. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 29, co-authored 193 publications.
Chat about Author
Papers
Coexistence of HLA and KIR ligand mismatches as a risk factor for viral infection early after cord blood transplantation
Tomoki Iemura,Yasuyuki Arai,Toshio Kitawaki,Junya Kanda,Tadakazu Kondo,Yasunori Ueda,T Mori,Kazunori Imada,Akihito Yonezawa,Kazuhiro Yago,Naoyuki Anzai,Shinichi Kotani,Masaharu Nohgawa,Toshiyuki Kitano,Mitsuru Itoh,Nobuyoshi Arima,Toshinori Moriguchi,Mitsumasa Watanabe,Masaaki Tsuji,Kouhei Yamashita,Akifumi Takaori-Kondo +20 more
TL;DR: The study demonstrates the unfavorable impacts of HLA & KIR mismatches on viral infections and non-relapse mortality after CBT and suggests that optimizing the graft selection algorithm could improve the outcome of CBTs.
3
Metronidazole-induced encephalopathy during treatment for refractory diarrhea after cord blood transplantation.
Tomoki Iemura,Toshiyuki Kitano,Akira Ishii,Masakatsu Hishizawa,Tadakazu Kondo,Kouhei Yamashita,Akifumi Takaori-Kondo +6 more
TL;DR: Patients with CCS often have recurrent diarrhea after the discontinuation of MNZ and may require prolonged treatment for a median of 120 days and when treating CCS with MNZ, physicians should be alert for the development of MIE.
3
Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study.
Keiji Okinaka,Yoshitaka Inoue,Naoyuki Uchida,Takashi Toya,Hiroyasu Ogawa,Yukiyasu Ozawa,Tetsuya Eto,Takehiko Mori,Junichi Sugita,Tadakazu Kondo,Koji Kato,Ritsuro Suzuki,Takahiro Fukuda +12 more
TL;DR: In this paper , the authors used a transplant registry database between January 1, 2001 and December 31, 2011 to assess the clinical spectrum and risk factors for pneumococcal diseases in the late post-transplant period.
3
Aplastic Anemia Treated with Eltrombopag during Pregnancy
Yuri Suminaga,Yoshitsugu Chigusa,Tadakazu Kondo,H. Okamoto,Yosuke Kawamura,Mana Taki,Masaki Mandai,Haruta Mogami +7 more
TL;DR: If limited to refractory cases and with adequate maternal and fetal monitoring, including neonatal blood examinations, the use of eltrombopag for patients with aplastic anemia during pregnancy may be acceptable and result in favorable maternal and Fetal outcomes.
3
Changes in the health-related quality of life and social reintegration status after lung transplantation following hematopoietic stem cell transplantation.
Ryota Hamada,Yohei Oshima,Susumu Sato,Yuji Yoshioka,Manabu Nankaku,Tadakazu Kondo,Toyofumi F. Chen-Yoshikawa,Ryosuke Ikeguchi,Daisuke Nakajima,Hiroshi Date,Shuichi Matsuda +10 more
TL;DR: Wang et al. as mentioned in this paper investigated the recovery in HRQoL and social reintegration status after lung transplantation in patients with late-onset non-infectious pulmonary complications (LONIPCs) after allogeneic hematopoietic stem cell transplantation.
3